A5022857276- Streptococcal Infections and Treatments
- Infective Endocarditis Diagnosis and Management
- Multiple and Secondary Primary Cancers
- Otolaryngology and Infectious Diseases
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- Bacterial Identification and Susceptibility Testing
- Tuberculosis Research and Epidemiology
- Bacteriophages and microbial interactions
- Pharmaceutical and Antibiotic Environmental Impacts
- Bacterial biofilms and quorum sensing
- Childhood Cancer Survivors' Quality of Life
- Neonatal and Maternal Infections
- Antibiotic Resistance in Bacteria
- Health Systems, Economic Evaluations, Quality of Life
- Botulinum Toxin and Related Neurological Disorders
- Hepatitis C virus research
- Hepatitis B Virus Studies
- Antibiotic Use and Resistance
- Diphtheria, Corynebacterium, and Tetanus
- Antifungal resistance and susceptibility
- Clostridium difficile and Clostridium perfringens research
Kindai University Hospital
2010-2024
Osaka University
2023-2024
Tokyo Women's Medical University
2018
Gemella is a catalase-negative, facultative anaerobic, Gram-positive coccus that commensal in humans but can become opportunistic and cause severe infectious diseases, such as infective endocarditis. Few studies have tested the antimicrobial susceptibility of Gemella. We its to 27 drugs defined resistant genes using PCR 58 strains, including 52 clinical isolates six type strains. The strains included 22 G. morbillorum, 18 haemolysans (GH) group (genetically indistinguishable from...
Gemella bergeri is one of the nine species genus and relatively difficult to identify. We herein describe first case septic shock due a coinfection with Eikenella corrodens. A 44-year-old Asian man medical history IgG4-related ophthalmic disease who was prescribed corticosteroids (prednisolone) presented our hospital dyspnea. On arrival, he in shock, purpuric eruption noted on both legs. Contrast enhanced computed tomography showed fluid retention at right maxillary sinus, left lung ground...
The quantification of hepatitis B virus (HBV) DNA is used to monitor antiviral treatment for HBV infection. Recently, an HBV-DNA reagent and assay protocol have been developed the µTASWako g1 (Fujifilm Wako Pure Chemical Corporation, Osaka, Japan), a fully automated genetic analyzer that uses PCR-capillary electrophoresis. We evaluated performance newly using standard clinical samples.The was 3rd World Health Organization International Standard HBV. Thereafter, we correlation between serum...